(Total Views: 478)
Posted On: 03/22/2025 12:18:55 AM
Post# of 154885
Re: sherlock57 #151063
Quote:
Sure, some company might want to pair something with LL to deal with liver fibrosis... But at this stage of the game they are pretty far behind in the MASH "race".
We are ready to go to a phase 3 dose escalation trial. We aren't because of cash flow.
(7)
(0)
